Metraipolis › archive › dc_8773e46dd6ce

Altering PTPRD via genetics or pharmacology modulates 3xTg-AD mouse neurofibrillary pathology — Europe PMC PMID:41987927

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41987927
DOI
10.3389/fnins.2026.1803332
License (as archived)
solo-consultazione
Archived
2026-11-03T14:30:48.248Z
SHA-256 of the archived text
f890f20bf1ddb3d1c5e108e12805206baf11bf5469423b002d8cb5203f3b7940
Stable URL of this page
https://metraipolis.com/documento/dc_8773e46dd6ce

How to cite

Altering PTPRD via genetics or pharmacology modulates 3xTg-AD mouse neurofibrillary pathology — Europe PMC PMID:41987927 — Europe PMC (en), https://europepmc.org/article/MED/41987927 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8773e46dd6ce (Metraipolis archive dc_8773e46dd6ce, sha256 f890f20bf1ddb3d1c5e108e12805206baf11bf5469423b002d8cb5203f3b7940)
BibTeX
@misc{dc8773e46dd6ce,
  title = {Altering PTPRD via genetics or pharmacology modulates 3xTg-AD mouse neurofibrillary pathology — Europe PMC PMID:41987927},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41987927},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8773e46dd6ce; sha256 f890f20bf1ddb3d1c5e108e12805206baf11bf5469423b002d8cb5203f3b7940},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41987927. Agents can read the archived copy with the MCP tool read_document.